The presented results lead us to advocate a new DNA-based treatment for pancreatic cancer, inducing cytotoxic effect in cancer cells by intratumoral injection of a naked DNA vector containing the DT-A gene under the control of H19 regulatory sequences for human pancreatic cancer. The gene discussed is H19; the disease is pancreatic neoplasm.